WO2019054468A1 - Method of freeing cells from cell-containing sample - Google Patents

Method of freeing cells from cell-containing sample Download PDF

Info

Publication number
WO2019054468A1
WO2019054468A1 PCT/JP2018/034107 JP2018034107W WO2019054468A1 WO 2019054468 A1 WO2019054468 A1 WO 2019054468A1 JP 2018034107 W JP2018034107 W JP 2018034107W WO 2019054468 A1 WO2019054468 A1 WO 2019054468A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
container
cell
enzyme
cells
Prior art date
Application number
PCT/JP2018/034107
Other languages
French (fr)
Japanese (ja)
Inventor
林 真司
Original Assignee
株式会社カネカ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社カネカ filed Critical 株式会社カネカ
Priority to JP2019542298A priority Critical patent/JP7282679B2/en
Publication of WO2019054468A1 publication Critical patent/WO2019054468A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/26Inoculator or sampler

Definitions

  • FIG. 1 An example of the bag for enzyme processing (bag-like container) for performing an enzyme processing of a cell containing sample is shown. It is a cross-sectional schematic diagram for demonstrating the state of the reaction liquid mixture containing a cell containing sample and an enzyme, and the gaseous phase in the bag for enzyme processing.
  • the enzyme processing bag shown in FIG. 1 to which the reaction mixture containing the cell-containing sample and the enzyme and the gas phase (containing material) have been added is sealed with a clamp, and the container of the enzyme processing bag is contained. It is a schematic diagram for demonstrating that the volume of the part to accommodate was adjusted so that it might correspond with the volume of a container.
  • the other example of the bag (bag-like container) for enzyme processing for performing an enzyme processing of a cell containing sample is shown.
  • the other example of the bag (bag-like container) for enzyme processing for performing an enzyme processing of a cell containing sample is shown.
  • the bag-like container used in the present invention is a bag-like container formed of a material having flexibility (also referred to as flexibility). It is preferable that the bag-like container is at least partially made of a transparent or translucent material, because the appearance of the cell suspension inside can be visually observed.
  • the flexible material forming the bag-like container include soft vinyl chloride, vinyl chloride, polyurethane, ethylene-vinyl acetate copolymer, polyolefin such as polyethylene and polypropylene, styrene-butadiene-styrene copolymer Or a thermoplastic elastomer such as a hydrogenated substance thereof and a styrene-isoprene-styrene copolymer or a hydrogenated substance thereof, and a mixture of a thermoplastic elastomer and a softener such as a polyolefin and ethylene-ethyl acrylate, etc.
  • the resin which it has is mentioned.
  • the end portion of the first resin sheet 11 is disposed between the first resin sheet 11 and the second resin sheet 12 on the side of one end in the longitudinal direction of the container main body 10, and the first resin sheet 11 and the second resin sheet 12 around it. Are joined by heat fusion and integrated with the container body 10. Similarly, the tube portion 311 of the first outlet port 31 and the tube portion 321 of the second outlet port 32 have longitudinal ends on the side where the needleless ports 312 and 322 are not disposed.
  • the plan view of the storage portion of the bag-like container is a plan view in a state where the empty bag-like container is spread on a plane so as to widen the area. It is preferable that A / B is the said range in the bag-like container which especially arrange
  • the plan view shape of the storage portion of the bag-like container is not limited to a substantially quadrangle as shown in FIG. 1, and may be any shape such as a circle, an ellipse, a triangle, or a pentagon or more polygon. 1 to 6 show the width A in the width direction and the width B in the longitudinal direction when the entire storage portion 14 is used as the storage portion in the bag-like container 1 whose plan view shape of the storage portion 14 is substantially square.
  • the adipose tissue from 5 persons was treated with collagenase and the steps of preparing the cell suspension under different conditions.
  • a second bag for enzyme treatment (bag-like container 1)
  • two roughly rectangular flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are disposed opposite to each other, and one end side in the longitudinal direction
  • a first inlet port 21, a second inlet port 22, and a third inlet port 23 are provided, and a first outlet port 31 and a second outlet port 32 are provided on the other end side, and the peripheral portion is fused by heat fusion.
  • Forming a fusion-bonded portion 13 to form a bag which is sandwiched between the two sheets 11 and 12 and has a substantially rectangular storage portion 14 having an inner dimension of 67 mm in width and 116 mm in length in an empty state Using.
  • the internal volume of the storage portion 14 of the second enzyme treatment bag is about 120 mL.
  • the fifth bag for enzyme treatment (bag-like container 1) shown in FIG. 6, two approximately rectangular flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are oppositely disposed, and one end in the longitudinal direction
  • the inlet port / outlet port 61 is provided on the side of the sheet, and the peripheral part is fusion-bonded by heat fusion to form the fusion-bonded part 13 so that the two sheets 11 and 12 are empty.
  • the bag is a bag in which a substantially rectangular housing portion 14 having an inner dimension of 18 mm in width and 187.7 mm in length is formed.
  • the internal volume of the container 14 for the fifth enzyme treatment bag is about 22 mL.
  • the outlet port 51 of the third enzyme treatment bag 1 is closed with a lid 313, and 20 mL of adipose tissue and 20 mL of collagenase solution are accommodated in the accommodation portion 14 to form a reaction mixture solution 201, and is accommodated. 3 mL of air is added so that the volume of the air phase 202 in the section 14 becomes 7% of the volume of the accommodation section 14, and the inlet port 41 of the third enzyme treatment bag 1 is sealed with a lid 413 for sealing did.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

In order to free nucleated cells from a cell-containing sample such as fatty tissue with enzyme treatment, this method of freeing cells from a cell-containing sample by subjecting the cell-containing sample to enzyme treatment is characterized by involving a step for agitating a bag-shaped container 1 in which a gaseous phase 202 and a reaction mixture 201 containing the cell-containing sample and an enzyme are housed and sealed, wherein the ratio of the volume of the gaseous phase 202 is at least 7 vol% of the total volume of the gaseous phase 202 and the reaction mixture 201.

Description

細胞含有試料からの細胞の遊離方法Method of releasing cells from cell-containing sample
 本発明は、生体組織等の細胞含有試料を酵素処理することで、細胞含有試料が細胞を遊離させる方法に関する。 The present invention relates to a method in which a cell-containing sample liberates cells by enzymatically treating a cell-containing sample such as a living tissue.
 脂肪組織に含まれる有核細胞の少なくとも一部は生体組織幹細胞であり、それらは成熟脂肪細胞、骨細胞、軟骨細胞、筋芽細胞、血管内皮細胞等、様々な細胞へと分化可能であることが知られている。このような多分化能を有する脂肪由来生体組織幹細胞を効率良く分離・採取する方法は、再生医療発展の見地から極めて重要である。 At least a part of nucleated cells contained in adipose tissue are living tissue stem cells, which can be differentiated into various cells such as mature adipocytes, bone cells, chondrocytes, myoblasts, vascular endothelial cells, etc. It has been known. A method for efficiently separating and collecting such pluripotent adipose-derived living tissue stem cells is extremely important from the viewpoint of regenerative medicine development.
 脂肪組織等の、有用細胞を含む生体組織から、有用細胞を取得する方法として、消化酵素で生体組織を分解して有用細胞を遊離させ、その後に遠心分離、濾過等の分離工程を経て有用細胞を回収する方法が知られている。 As a method of obtaining useful cells from living tissue including useful cells such as adipose tissue, the living tissue is degraded with digestive enzymes to release useful cells, and then the cells are subjected to separation steps such as centrifugation, filtration and the like to obtain useful cells. Methods for recovering are known.
 例えば特許文献1の実施例1では、50mL容の遠心チューブに、脂肪組織とコラゲナーゼ液とを収容し、37℃、120回/minの条件で1時間振盪させて酵素反応を行い、その後にフィルターろ過及び遠心分離を行い、沈渣として沈降細胞集団(SVF画分)を取得することが記載されている。 For example, in Example 1 of Patent Document 1, an adipose tissue and a collagenase solution are accommodated in a 50 mL centrifugal tube, shaken at 37 ° C., 120 times / min for 1 hour to perform an enzyme reaction, and then a filter It is described that filtration and centrifugation are performed to obtain a precipitated cell population (SVF fraction) as sediment.
 特許文献2には、脂肪組織試料から非脂肪細胞を分離するための装置として、第1シートの物質と、前記第1シートの物質に結合された第2シートの物質と、前記第1シートの物質と前記第2シートの物質との間で画成された複数のチャンバとを備える装置が開示されている。そして、複数のチャンバの1つである第1チャンバ内で、脂肪組織試料を、コラゲナーゼ等の酵素を含む解離溶液により処理して、脂肪組織試料を解離することが開示されている。 According to Patent Document 2, as a device for separating non-fat cells from a fat tissue sample, a substance of a first sheet, a substance of a second sheet bonded to the substance of the first sheet, and a substance of the first sheet An apparatus is disclosed comprising a plurality of chambers defined between a substance and the substance of the second sheet. Then, it is disclosed that the adipose tissue sample is treated with a dissociation solution containing an enzyme such as collagenase to dissociate the adipose tissue sample in a first chamber which is one of a plurality of chambers.
国際公開第2008/018450号International Publication No. 2008/018450 特表2015-500031号公報Japanese Patent Publication No. 2015-500031
 生体組織等の、細胞を含む細胞含有試料から、細胞を遊離させるために、細胞含有試料を酵素処理する方法が従来から行われている。 In order to release cells from a cell-containing sample containing cells, such as a living tissue, a method of enzymatically treating the cell-containing sample has been conventionally performed.
 しかし、目的とする細胞の回収量と、細胞含有試料から細胞を遊離させるための酵素処理時の容器、振盪方法等の条件との関係はこれまで十分に検討されているとは言えない。 However, the relationship between the target amount of recovered cells and the conditions such as the container for enzyme treatment for releasing cells from the cell-containing sample and the shaking method has not been sufficiently studied.
 本発明者らは、驚くべきことに、特許文献1のように細胞含有試料の酵素処理を柔軟性のない通常の遠沈管内で振盪させながら行った場合に、十分な数の有核細胞が取得できないことを見出した。本発明者らはまた、驚くべきことに、柔軟性を有する袋状容器内に細胞含有試料と酵素液とを通常の方法で空気を含まないように充填し、振盪させながら酵素処理を行った場合にも、十分な数の有核細胞が取得できないことを見出した。そして本発明者らは鋭意検討した結果、次の方法を完成するに至った。 The present inventors have surprisingly found that a sufficient number of nucleated cells are obtained when enzyme treatment of a cell-containing sample is carried out while shaking in a conventional flexible tube, as in Patent Document 1. I found that I could not get it. The inventors also surprisingly found that the cell-containing sample and the enzyme solution were filled in a flexible bag-like container without using air in the usual manner, and the enzyme treatment was carried out while shaking. Also, we found that a sufficient number of nucleated cells could not be obtained. As a result of intensive studies, the present inventors have completed the following method.
(1)細胞含有試料を酵素処理して、細胞含有試料から細胞を遊離させる方法であって、
 細胞含有試料と酵素とを含む反応混合液及び気相を、反応混合液と気相との合計体積に対して気相の体積が7体積%以上となる割合で収容し閉鎖した袋状容器を振盪させる工程を含むことを特徴とする方法。
(2)細胞含有試料が脂肪組織である、(1)に記載の方法
(3)袋状容器の反応混合液及び気相を収容する収容部の、平面視での、短手方向幅をAとし長手方向幅をBとしたとき、A/Bが0.1以上1以下である、(1)又は(2)に記載の方法。
 本明細書は本願の優先権の基礎となる日本国特許出願番号2017-178267の開示内容を包含する。
(1) A method of enzymatically treating a cell-containing sample to release cells from the cell-containing sample,
A closed container comprising a reaction mixture containing a cell-containing sample and an enzyme and a gas phase is contained at a ratio of 7 vol% or more of the volume of the gas phase to the total volume of the reaction mixture and the gas phase. A method characterized in that it comprises the step of shaking.
(2) The method according to (1), wherein the cell-containing sample is a fat tissue (3) The width in the short direction of the container of the reaction mixture of the bag-like container and the gas phase The method according to (1) or (2), wherein A / B is 0.1 or more and 1 or less, where B is a longitudinal width.
The present specification includes the disclosure content of Japanese Patent Application No. 2017-178267 on which the priority of the present application is based.
 本発明の方法によれば、脂肪組織等の細胞含有試料から有核細胞の状態で遊離する細胞の量を高めることができる。 According to the method of the present invention, the amount of cells released in the form of nucleated cells from a cell-containing sample such as adipose tissue can be increased.
細胞含有試料の酵素処理を行うための酵素処理用バッグ(袋状容器)の一例を示す。An example of the bag for enzyme processing (bag-like container) for performing an enzyme processing of a cell containing sample is shown. 酵素処理用バッグ内での、細胞含有試料と酵素とを含む反応混合液及び気相の状態を説明するための断面模式図である。It is a cross-sectional schematic diagram for demonstrating the state of the reaction liquid mixture containing a cell containing sample and an enzyme, and the gaseous phase in the bag for enzyme processing. 細胞含有試料と酵素とを含む反応混合液及び気相(収容物)を加えた図1に示す酵素処理用バッグをクランプにより封止して、酵素処理用バッグの収容部のうち、収容物を収容する部分の体積を、収容物の体積と一致するように調節したことを説明するための模式図である。The enzyme processing bag shown in FIG. 1 to which the reaction mixture containing the cell-containing sample and the enzyme and the gas phase (containing material) have been added is sealed with a clamp, and the container of the enzyme processing bag is contained. It is a schematic diagram for demonstrating that the volume of the part to accommodate was adjusted so that it might correspond with the volume of a container. 細胞含有試料の酵素処理を行うための酵素処理用バッグ(袋状容器)の別の一例を示す。The other example of the bag (bag-like container) for enzyme processing for performing an enzyme processing of a cell containing sample is shown. 細胞含有試料の酵素処理を行うための酵素処理用バッグ(袋状容器)の別の一例を示す。The other example of the bag (bag-like container) for enzyme processing for performing an enzyme processing of a cell containing sample is shown. 細胞含有試料の酵素処理を行うための酵素処理用バッグ(袋状容器)の別の一例を示す。The other example of the bag (bag-like container) for enzyme processing for performing an enzyme processing of a cell containing sample is shown.
 以下、本発明を詳細に説明する。
<用語、材料>
 細胞含有試料としては生体組織、in vitroで調製した細胞培養物等が例示できる。生体組織は典型的には動物より採取した生体組織であり、例えば、脂肪、皮膚、血管、角膜、口腔、腎臓、肝臓、膵臓、心臓、神経、筋肉、前立腺、腸、羊膜、胎盤、臍帯などに由来する生体組織が挙げられる。本明細書で開示する方法は特に脂肪組織から間質血管画分(SVF)細胞を取り出すのに有用である。
Hereinafter, the present invention will be described in detail.
<Terms, Materials>
Examples of cell-containing samples include living tissues, and cell cultures prepared in vitro. The biological tissue is typically a biological tissue collected from an animal, such as fat, skin, blood vessels, cornea, oral cavity, kidney, liver, pancreas, heart, nerve, muscle, prostate, intestine, amniotic membrane, placenta, umbilical cord, etc. And biological tissues derived from The methods disclosed herein are particularly useful for removing interstitial vascular fraction (SVF) cells from adipose tissue.
 脂肪組織とは典型的には哺乳動物の脂肪組織であり、例えば、ヒト由来の皮下脂肪、内臓脂肪、白色脂肪、褐色脂肪である。脂肪組織は、任意の形状であってよく、例えば、脂肪組織をハサミ等の鋭利な器具を用いて破砕したもの、濾し器等を用いてミンチ状にしたもの、脂肪吸引法を用いて分解したものであってよい。ここで脂肪吸引法とは、一般的な美容成形外科で行なわれている吸引法であれば特に限定されず、例えば、超音波脂肪吸引、カニューレ等を用いたパワードリポサクション、シリンジ吸引等による方法である。
 有核細胞とは、細胞内に核を有する細胞である。
The adipose tissue is typically mammalian adipose tissue, such as subcutaneous fat of human origin, visceral fat, white fat and brown fat. Adipose tissue may have any shape, for example, one obtained by crushing adipose tissue using a sharp instrument such as scissors, one obtained by mincing using a filter, etc., or one obtained by decomposition using liposuction. It may be Here, the liposuction method is not particularly limited as long as it is a suction method performed in general cosmetic surgery, and for example, a method by ultrasonic liposuction, powered liposome suction using a cannula or the like, syringe suction, etc. It is.
A nucleated cell is a cell having a nucleus in the cell.
 本発明において遊離される細胞としては、生体組織幹細胞、白血球、単球、顆粒球、リンパ球、血管内皮細胞、血管内皮前駆細胞、周細胞等、細胞治療や実験等の目的で採取が必要とされる有核細胞が例示できる。生体組織幹細胞は、好ましくは、脂肪由来間葉系幹細胞、脂肪由来間質幹細胞であり、より好ましくは細胞表面のCD34、73、90、105、106、133、166から選ばれる少なくとも一つを発現している脂肪由来間葉系細胞、脂肪由来間質幹細胞である。 In the present invention, cells to be released in the present invention include stem cells, white blood cells, monocytes, granulocytes, lymphocytes, vascular endothelial cells, vascular endothelial precursor cells, pericytes, etc., which need to be collected for cell therapy and experiments. Nucleated cells can be exemplified. The living tissue stem cells are preferably fat-derived mesenchymal stem cells, fat-derived stromal stem cells, and more preferably express at least one selected from CD34, 73, 90, 105, 106, 133, 166 on the cell surface Fat-derived mesenchymal cells, fat-derived stromal stem cells.
 細胞含有試料から細胞を遊離させるための酵素としては、コラゲナーゼ、メタロプロテアーゼ、ディスパーゼ、トリプシン、ヒアルロニダーゼ、キモトリプシン、ペプシン、アミノペプチダーゼ、リパーゼ、アミラーゼ及びそれらのリコンビナントから選ばれる少なくとも1種の分解酵素が使用できる。細胞含有試料として生体組織、特に脂肪組織を用いる場合には、酵素としては、短時間に、かつ低侵襲で分解するという観点から、コラゲナーゼ、メタロプロテアーゼ、ディスパーゼ、トリプシン及びヒアルロニダーゼから選択される少なくとも1種の分解酵素が好ましい。 As an enzyme for releasing cells from a cell-containing sample, at least one degradation enzyme selected from collagenase, metalloprotease, dispase, trypsin, hyaluronidase, chymotrypsin, pepsin, aminopeptidase, lipase, amylase and their recombinants is used it can. When a living tissue, in particular an adipose tissue, is used as the cell-containing sample, at least one selected from collagenase, metalloprotease, dispase, trypsin and hyaluronidase from the viewpoint of degradation in a short time and minimally invasive manner as an enzyme Species degrading enzymes are preferred.
<袋状容器>
 本発明で用いる袋状容器は、柔軟性(可撓性ともいう)を有する材料により形成された袋状の容器である。袋状容器は、少なくとも一部を透明または半透明の材料からなるものとすると、内部の細胞懸濁液の様子を目視で観察できるため好ましい。
<Bag-like container>
The bag-like container used in the present invention is a bag-like container formed of a material having flexibility (also referred to as flexibility). It is preferable that the bag-like container is at least partially made of a transparent or translucent material, because the appearance of the cell suspension inside can be visually observed.
 袋状容器を形成する柔軟性を有する材料の具体例としては、軟質塩化ビニル、塩化ビニル、ポリウレタン、エチレン-酢酸ビニル共重合体、ポリエチレンやポリプロピレンのようなポリオレフィン、スチレン-ブタジエン-スチレン共重合体又はその水添物及びスチレン-イソプレン-スチレン共重合体またはその水添物等の熱可塑性エラストマー、ならびに、熱可塑性エラストマーとポリオレフィン及びエチレン-エチルアクリレート等の軟化剤との混合物等の、柔軟性を有する樹脂が挙げられる。 Specific examples of the flexible material forming the bag-like container include soft vinyl chloride, vinyl chloride, polyurethane, ethylene-vinyl acetate copolymer, polyolefin such as polyethylene and polypropylene, styrene-butadiene-styrene copolymer Or a thermoplastic elastomer such as a hydrogenated substance thereof and a styrene-isoprene-styrene copolymer or a hydrogenated substance thereof, and a mixture of a thermoplastic elastomer and a softener such as a polyolefin and ethylene-ethyl acrylate, etc. The resin which it has is mentioned.
 袋状容器が樹脂シートにより形成される実施形態では、樹脂シートの厚さは特に限定されないが、例えば0.2mm~0.6mmであることができる。 In the embodiment in which the bag-like container is formed of a resin sheet, the thickness of the resin sheet is not particularly limited, but can be, for example, 0.2 mm to 0.6 mm.
 袋状容器は、好ましくは、柔軟性を有する樹脂のシートにより壁面が形成された容器であり、特に好ましくは、柔軟性を有する樹脂シートを2枚重対向配置し、周縁部を熱融着又は接着剤により接合して袋状に形成した容器である。 The bag-like container is preferably a container whose wall surface is formed of a flexible resin sheet, and particularly preferably, the flexible resin sheets are disposed in a double-layer facing manner and the peripheral portion is heat-sealed or It is a container joined by an adhesive and formed in a bag shape.
 2枚の柔軟性を有する樹脂シートにより形成される袋状容器の具体的な実施形態を、図1を参照して説明する。 A specific embodiment of a bag-like container formed of two flexible resin sheets will be described with reference to FIG.
 本実施形態の容器1は、容器本体10、第1入口ポート21、第2入口ポート22、第3入口ポート23、第1出口ポート31、第2出口ポート32を備える。 The container 1 of this embodiment includes a container body 10, a first inlet port 21, a second inlet port 22, a third inlet port 23, a first outlet port 31, and a second outlet port 32.
 第1入口ポート21は、液体の流路を形成する管部211と、管部211の入口を連通可能に封鎖するメスルアーロック212と、メスルアーロック212を保護する着脱自在の蓋部213と、管部211を通る液体を濾過するフィルター部214とを備える。 The first inlet port 21 includes a tube portion 211 forming a flow path of liquid, a female luer lock 212 which closes the inlet of the tube portion 211 so that the inlet can be communicated, and a removable lid 213 which protects the female luer lock 212. And the filter part 214 which filters the liquid which passes the pipe part 211. FIG.
 第2入口ポート22は、液体の流路を形成する管部221と、管部221の入口を連通可能に封鎖するニードルレスポート222と、ニードルレスポート222を保護する着脱自在の蓋部223とを備える。 The second inlet port 22 includes a pipe portion 221 that forms a flow path of liquid, a needleless port 222 that blocks the inlet of the pipe portion 221 so as to allow communication with it, and a removable lid 223 that protects the needleless port 222. Equipped with
 第3入口ポート23は、液体の流路を形成する管部231と、管部231の入口を連通可能に封鎖するニードルレスポート232と、ニードルレスポート232を保護する着脱自在の蓋部233とを備える。 The third inlet port 23 includes a tube portion 231 which forms a flow path of liquid, a needleless port 232 which closes the inlet of the tube portion 231 so as to allow communication with it, and a detachable lid 233 which protects the needleless port 232. Equipped with
 第1出口ポート31は、液体の流路を形成する管部311と、管部311の出口を連通可能に封鎖するニードルレスポート312と、ニードルレスポート312を保護する着脱自在の蓋部313とを備える。 The first outlet port 31 includes a pipe portion 311 forming a flow path of liquid, a needleless port 312 for sealing the outlet of the pipe portion 311 so as to allow communication with it, and a removable lid 313 for protecting the needleless port 312. Equipped with
 第2出口ポート32は、液体の流路を形成する管部321と、管部321の出口を連通可能に封鎖するニードルレスポート322と、ニードルレスポート322を保護する着脱自在の蓋部323とを備える。 The second outlet port 32 has a pipe portion 321 forming a flow path of liquid, a needleless port 322 which closes the outlet of the pipe portion 321 in a manner that allows communication with it, and a removable lid 323 which protects the needleless port 322. Equipped with
 容器本体10は、概ね長方形の第1樹脂シート11と第2樹脂シート12とを対向配置し、周縁部を熱融着により接合して袋体としたものである。第1樹脂シート11と第2樹脂シート12が熱融着により接合した部分を融着部13とする。容器本体10には、第1樹脂シート11と第2樹脂シート12との間に収容部14が形成されている。収容部14において後述する酵素処理が行われる。第1入口ポート21の管部211、第2入口ポート22の管部221及び第3入口ポート23の管部231は、それらのメスルアーロック212、ニードルレスポート222、232が配置されていない側の端部が、容器本体10の長手方向の一端の辺上の、第1樹脂シート11と第2樹脂シート12との間に配置され、その周りの第1樹脂シート11と第2樹脂シート12が熱融着により接合されて、容器本体10と一体化されている。同様に、第1出口ポート31の管部311及び第2出口ポート32の管部321は、それらのニードルレスポート312、322が配置されていない側の端部が、容器本体10の長手方向の他端の辺上の、第1樹脂シート11と第2樹脂シート12との間に配置され、その周りの第1樹脂シート11と第2樹脂シート12が熱融着により接合されて、容器本体10と一体化されている。第1入口ポート21の管部211、第2入口ポート22の管部221、第3入口ポート23の管部231、第1出口ポート31の管部311及び第2出口ポート32の管部321は、それぞれ、容器本体10の収容部14と容器本体10の外側とを連通する流路であり、メスルアーロック212、ニードルレスポート222、232、312、322を介して他の流路と連通可能である。 The container body 10 has a substantially rectangular first resin sheet 11 and a second resin sheet 12 disposed opposite to each other, and peripheral portions thereof are joined by heat fusion to form a bag. A portion where the first resin sheet 11 and the second resin sheet 12 are joined by heat fusion is referred to as a fusion part 13. In the container body 10, a housing portion 14 is formed between the first resin sheet 11 and the second resin sheet 12. In the storage unit 14, an enzyme treatment described later is performed. The pipe portion 211 of the first inlet port 21, the pipe portion 221 of the second inlet port 22, and the pipe portion 231 of the third inlet port 23 are the sides on which the female luer lock 212 and the needleless ports 222 and 232 are not disposed. The end portion of the first resin sheet 11 is disposed between the first resin sheet 11 and the second resin sheet 12 on the side of one end in the longitudinal direction of the container main body 10, and the first resin sheet 11 and the second resin sheet 12 around it. Are joined by heat fusion and integrated with the container body 10. Similarly, the tube portion 311 of the first outlet port 31 and the tube portion 321 of the second outlet port 32 have longitudinal ends on the side where the needleless ports 312 and 322 are not disposed. The container body is disposed between the first resin sheet 11 and the second resin sheet 12 on the side of the other end, and the first resin sheet 11 and the second resin sheet 12 around it are joined by heat fusion to form the container body Integrated with 10 The pipe portion 211 of the first inlet port 21, the pipe portion 221 of the second inlet port 22, the pipe portion 231 of the third inlet port 23, the pipe portion 311 of the first outlet port 31, and the pipe portion 321 of the second outlet port 32 These are channels that respectively communicate the housing portion 14 of the container body 10 with the outside of the container body 10, and can communicate with other channels via the female luer lock 212 and the needleless ports 222, 232, 312, 322. It is.
 本実施形態では容器本体10の第1~第3入口ポート21、22、23が配置される側の辺の両端の、融着部13よりも外側の部分に、貫通孔15、15が形成されている。貫通孔15は容器1をフックなどに掛けるために用いることができる。 In the present embodiment, through holes 15, 15 are formed in portions outside the fused portion 13 at both ends of the side where the first to third inlet ports 21, 22, 23 of the container main body 10 are disposed. ing. The through hole 15 can be used to hook the container 1 on a hook or the like.
 2枚の柔軟性を有する樹脂シートにより形成される袋状容器の別の実施形態を、図4に示す。
 本実施形態の容器1は、容器本体10、入口ポート41及び出口ポート51を備える。
Another embodiment of a bag-like container formed of two flexible resin sheets is shown in FIG.
The container 1 of the present embodiment includes a container body 10, an inlet port 41 and an outlet port 51.
 入口ポート41は、液体の流路を形成する管部411と、管部411の入口を連通可能に封鎖するメスルアーロック412と、メスルアーロック412を保護する着脱自在の蓋部413を備える。 The inlet port 41 includes a pipe portion 411 forming a liquid flow path, a female luer lock 412 sealingly closing the inlet of the pipe portion 411 and a removable lid 413 protecting the female luer lock 412.
 出口ポート51は、液体の流路を形成する管部521と、管部521の入口を連通可能に封鎖するニードルレスポート522と、ニードルレスポート522を保護する着脱自在の蓋部523とを備える。 The outlet port 51 includes a tube portion 521 that forms a flow path of liquid, a needleless port 522 that closes the inlet of the tube portion 521 in a manner that allows communication with it, and a removable lid 523 that protects the needleless port 522. .
 容器本体10は、概ね正方形の第1樹脂シート11と第2樹脂シート12とを対向配置し、周縁部を熱融着により接合して袋体としたものである。第1樹脂シート11と第2樹脂シート12が熱融着により接合した部分を融着部13とする。図4に示す実施形態における、容器本体10、入口ポート41及び出口ポート51の構造及び機能は、図1に示す実施形態と同様であり説明を省略する。 The container body 10 has a substantially square first resin sheet 11 and a second resin sheet 12 disposed opposite to each other, and peripheral portions thereof are joined by heat fusion to form a bag. A portion where the first resin sheet 11 and the second resin sheet 12 are joined by heat fusion is referred to as a fusion part 13. The structures and functions of the container body 10, the inlet port 41 and the outlet port 51 in the embodiment shown in FIG. 4 are the same as those in the embodiment shown in FIG.
 2枚の柔軟性を有する樹脂シートにより形成される袋状容器の別の実施形態を、図5に示す。
 本実施形態の容器1は、容器本体10及び入口ポート兼出口ポート61を備える。
Another embodiment of a bag-like container formed of two flexible resin sheets is shown in FIG.
The container 1 of the present embodiment includes a container body 10 and an inlet port / outlet port 61.
 入口ポート兼出口ポート61は、液体の流路を形成する管部611と、管部611の入口を連通可能に封鎖するメスルアーロック612と、メスルアーロック612を保護する着脱自在の蓋部613を備える。 The inlet port / outlet port 61 includes a pipe portion 611 which forms a flow path of liquid, a female luer lock 612 which closes the inlet of the tubular portion 611 so that the inlet can be communicated with it, and a removable lid 613 which protects the female luer lock 612. Equipped with
 容器本体10は、概ね長方形の第1樹脂シート11と第2樹脂シート12とを対向配置し、周縁部を熱融着により接合して袋体としたものである。第1樹脂シート11と第2樹脂シート12が熱融着により接合した部分を融着部13とする。図5に示す実施形態における、容器本体10及び入口ポート兼出口ポート61の構造及び機能は、図1に示す実施形態と同様であり説明を省略する。 The container body 10 has a substantially rectangular first resin sheet 11 and a second resin sheet 12 disposed opposite to each other, and peripheral portions thereof are joined by heat fusion to form a bag. A portion where the first resin sheet 11 and the second resin sheet 12 are joined by heat fusion is referred to as a fusion part 13. The structures and functions of the container body 10 and the inlet port / outlet port 61 in the embodiment shown in FIG. 5 are the same as those in the embodiment shown in FIG.
 2枚の柔軟性を有する樹脂シートにより形成される袋状容器の別の実施形態を、図6に示す。
 本実施形態の容器1は、容器本体10及び入口ポート兼出口ポート61を備える。
Another embodiment of a bag-like container formed of two flexible resin sheets is shown in FIG.
The container 1 of the present embodiment includes a container body 10 and an inlet port / outlet port 61.
 容器本体10は、概ね長方形の第1樹脂シート11と第2樹脂シート12とを対向配置し、周縁部を熱融着により接合して袋体としたものである。第1樹脂シート11と第2樹脂シート12が熱融着により接合した部分を融着部13とする。図5に示す実施形態における、容器本体10及び入口ポート兼出口ポート61の構造及び機能は、図1に示す実施形態と同様であり説明を省略する。図6に示す実施形態における、入口ポート兼出口ポート61の構造及び機能は、図5に示す実施形態と同様であり説明を省略する。 The container body 10 has a substantially rectangular first resin sheet 11 and a second resin sheet 12 disposed opposite to each other, and peripheral portions thereof are joined by heat fusion to form a bag. A portion where the first resin sheet 11 and the second resin sheet 12 are joined by heat fusion is referred to as a fusion part 13. The structures and functions of the container body 10 and the inlet port / outlet port 61 in the embodiment shown in FIG. 5 are the same as those in the embodiment shown in FIG. The structure and function of the inlet port / outlet port 61 in the embodiment shown in FIG. 6 are the same as those of the embodiment shown in FIG.
 本発明で用いる袋状容器は、好ましくは、平面視での、反応混合液及び気相を収容する収容部の短手方向幅をAとし長手方向幅をBとしたとき、A/Bが好ましくは0.1以上1以下、より好ましくは0.2以上1以下、より好ましくは0.3以上1以下、特に好ましくは0.5以上1以下である。A/Bがこの範囲の袋状容器を用いることにより、細胞含有試料から有核細胞の状態で遊離する細胞の量が顕著に増大するという驚くべき効果を奏する。その原因は必ずしも明らかではないが、振盪時に反応混合液が撹拌され易いことによると考えられる。 Preferably, the bag-like container used in the present invention has A / B when the width in the width direction of the container containing the reaction mixture and the gas phase in plan view is A and the width in the longitudinal direction is B. Is 0.1 or more and 1 or less, more preferably 0.2 or more and 1 or less, more preferably 0.3 or more and 1 or less, and particularly preferably 0.5 or more and 1 or less. The use of a bag-like container with A / B in this range produces a surprising effect that the amount of cells released in the form of nucleated cells from the cell-containing sample is significantly increased. Although the cause is not necessarily clear, it is considered that the reaction mixture is easily stirred at the time of shaking.
 ここで袋状容器の収容部の平面視とは、空の状態の袋状容器を、最も面積が広くなるように平面上に広げた状態での平面視である。特に、図1に示す袋状容器1のように、2枚のシートを対向配置し周囲を接合して形成した袋状容器においてA/Bが上記範囲であることが好ましい。袋状容器の収容部の平面視形状は、図1に示すような概ね四角形には限定されず、概ね円形、楕円形、三角形、五角形以上の多角形等の任意の形状であってよい。図1~6に、収容部14の平面視形状が概ね四角形の袋状容器1において、収容部14の全体を収容部として用いる場合の短手方向幅A、長手方向幅Bを示す。 Here, the plan view of the storage portion of the bag-like container is a plan view in a state where the empty bag-like container is spread on a plane so as to widen the area. It is preferable that A / B is the said range in the bag-like container which especially arrange | positions the sheet | seat of 2 sheets facing each other and it joins and forms like the bag-like container 1 shown in FIG. The plan view shape of the storage portion of the bag-like container is not limited to a substantially quadrangle as shown in FIG. 1, and may be any shape such as a circle, an ellipse, a triangle, or a pentagon or more polygon. 1 to 6 show the width A in the width direction and the width B in the longitudinal direction when the entire storage portion 14 is used as the storage portion in the bag-like container 1 whose plan view shape of the storage portion 14 is substantially square.
<酵素処理の方法>
 本発明は、
 細胞含有試料を酵素処理して細胞含有試料から細胞を遊離させる方法であって、
 細胞含有試料と酵素とを含む反応混合液及び気相を、反応混合液と気相との合計体積に対して気相の体積が7体積%以上となる割合で収容し閉鎖した袋状容器を振盪させる工程を含むことを特徴とする。
<Method of enzyme treatment>
The present invention
A method of enzymatically treating a cell-containing sample to release cells from the cell-containing sample,
A closed container comprising a reaction mixture containing a cell-containing sample and an enzyme and a gas phase is contained at a ratio of 7 vol% or more of the volume of the gas phase to the total volume of the reaction mixture and the gas phase. It is characterized by including a shaking step.
 この方法によると、柔軟性のない通常の遠沈管内で振盪させながら細胞含有試料の酵素処理を行う場合や、柔軟性を有する袋状容器内に細胞含有試料と酵素液とを通常の方法で空気を含まないように充填し、振盪させながら酵素処理を行う場合と比較して、細胞含有試料から有核細胞の状態で遊離する細胞の量が顕著に増大するという驚くべき効果を奏する。その原因は必ずしも明らかではないが、袋状容器の壁面は柔軟性を有するため、振盪中に遊離細胞が袋状容器の壁面に衝突しても衝撃が小さく損傷を受けにくいこと、容器内に気相が多く含まれるため振盪の際に反応混合液が気相により撹拌され易いこと等の原因によると推定される。 According to this method, the enzyme treatment of the cell-containing sample is carried out while shaking in a conventional flexible tube, or the cell-containing sample and the enzyme solution are contained in a flexible bag-like container by the usual method. This has the surprising effect that the amount of cells released in the form of nucleated cells from the cell-containing sample is significantly increased as compared to the case where the cells are packed without air and subjected to enzyme treatment while shaking. Although the cause is not necessarily clear, the wall surface of the bag-like container is flexible, so that even if free cells collide with the wall of the bag-like container during shaking, the impact is small and less likely to be damaged. It is presumed to be due to the fact that the reaction mixture is easily stirred by the gas phase during shaking because it contains a large amount of phases.
 本方法において、反応混合液は、細胞含有試料と酵素とを少なくとも含むものであればよいが、通常は、適当な水系媒体を更に含む。水系媒体としては、水、生理食塩水、リン酸緩衝液、ブドウ糖液、リンゲル液、ハンクス液、注射溶液、培地、等張液等が例示できる。 In the present method, the reaction mixture may be any one containing at least a cell-containing sample and an enzyme, but usually further contains a suitable aqueous medium. Examples of the aqueous medium include water, physiological saline, phosphate buffer, glucose solution, Ringer solution, Hanks solution, injection solution, culture medium, isotonic solution and the like.
 水系媒体を含む酵素処理開始時の反応混合液中では、酵素は、酵素が水系媒体中に溶解又は懸濁した液として存在する。この液を「酵素液」とする。酵素液は、予め酵素と水系媒体とを全量混合して酵素液としてから容器に投入したものに限らず、酵素、水系媒体を別々に容器に投入し、容器内で酵素液を形成したものも指す。酵素液の体積は、細胞含有試料の酵素処理を行うために容器内に投入された酵素、酵素液及び水系媒体の体積を合計して算出することができる。そして、袋状容器内に収容される反応混合液における、細胞含有試料と酵素液との割合は、生体組織等の細胞含有試料の体積に対して、酵素液の体積が、好ましくは50%~500%、より好ましくは60%~200%、より好ましくは70%~100%である。 In the reaction mixture containing an aqueous medium at the start of the enzyme treatment, the enzyme exists as a solution in which the enzyme is dissolved or suspended in the aqueous medium. This solution is called "enzyme solution". The enzyme solution is not limited to the one in which the whole amount of enzyme and aqueous medium are mixed and put into an enzyme solution and then put into the container, but the enzyme and the aqueous medium are separately put into the container and the enzyme solution is formed in the container Point to. The volume of the enzyme solution can be calculated by totaling the volumes of the enzyme, the enzyme solution and the aqueous medium which are introduced into the container in order to perform the enzyme treatment of the cell-containing sample. The ratio of the cell-containing sample to the enzyme solution in the reaction mixture contained in the bag-like container is preferably 50% of the volume of the enzyme solution with respect to the volume of the cell-containing sample such as a living tissue. It is 500%, more preferably 60% to 200%, more preferably 70% to 100%.
 気相は空気、窒素、酸素、不活性ガス等の気体の相であればよいが、好ましくは、空気の相である。 The gas phase may be a gas phase such as air, nitrogen, oxygen, inert gas and the like, but is preferably an air phase.
 反応混合液と気相との合計体積に対する気相の体積の割合は7体積%以上であり、好ましくは9体積%以上、より好ましくは15体積%以上、より好ましくは20体積%以上であり、上限は特に限定されないが、好ましくは80体積%以下、より好ましくは70体積%以下、より好ましくは65体積%以下である。 The ratio of the volume of the gas phase to the total volume of the reaction mixture and the gas phase is 7% by volume or more, preferably 9% by volume or more, more preferably 15% by volume or more, and more preferably 20% by volume or more. The upper limit is not particularly limited, but is preferably 80% by volume or less, more preferably 70% by volume or less, and more preferably 65% by volume or less.
 図2は、図1に示す袋状容器1の収容部14に、反応混合液201及び気相202を収容し、第1入口ポート21、第2入口ポート22、第3入口ポート23の側を鉛直方向上方に向けて配置した状態を示す。図示しないが、反応混合液201と気相202とを収容した袋状容器1を振盪する際には、第1入口ポート21、第2入口ポート22、第3入口ポート23、第1出口ポート31、第2出口ポート32は、それぞれメスルアーロック212、ニードルレスポート222、ニードルレスポート232、ニードルレスポート312、ニードルレスポート322により封鎖されている。細胞含有試料、酵素、水系媒体、空気等は、第1入口ポート21、第2入口ポート22、第3入口ポート23のいずれかから収容部14に供給すればよい。 2 stores the reaction mixture 201 and the gas phase 202 in the storage portion 14 of the bag-like container 1 shown in FIG. 1, and the side of the first inlet port 21, the second inlet port 22, and the third inlet port 23 is It shows a state where it is disposed vertically upward. Although not shown, when shaking the bag-like container 1 containing the reaction mixture 201 and the gas phase 202, the first inlet port 21, the second inlet port 22, the third inlet port 23, the first outlet port 31. The second outlet port 32 is sealed by the female luer lock 212, the needleless port 222, the needleless port 232, the needleless port 312, and the needleless port 322, respectively. The cell-containing sample, the enzyme, the aqueous medium, the air, and the like may be supplied to the storage unit 14 from any of the first inlet port 21, the second inlet port 22, and the third inlet port 23.
 反応混合液201と気相202とからなる収容物の体積が、袋状容器1の収容部14の内容積(収容部14が収容できる収容物の最大体積)と比較して大幅に小さい場合(例えば体積比で50%以下の場合)は、図3に示すように、袋状容器1をクランプ300により封止して、袋状容器1の収容部14のうち、収容物を収容する部分14Aの内容積を、収容物の体積と近くなるように調節してもよい。なお、図3は、反応混合液201と気相202を収容しクランプ300で封止した袋状容器1を水平面上に置き、平面視した図である。図3に示すように、袋状容器の収容部の全体を用いず、一部分のみに反応混合液及び気相を収容する場合は、上記の短手方向幅A及び長手方向幅Bは、反応混合液及び気相を収容する部分を平面視したときの短手方向幅及び長手方向幅を指す。具体的には、図3に示すように、袋状容器1をクランプ300により封止して形成される収容部14の部分14Aのみに反応混合液及び気相を収容する場合は、収容部14の部分14Aの短手方向幅をA、長手方向幅をBとする。 When the volume of the container consisting of the reaction mixture 201 and the gas phase 202 is much smaller than the internal volume of the container 14 of the bag-like container 1 (the maximum volume of the container which can be accommodated by the container 14) ( For example, in the case where the volume ratio is 50% or less), as shown in FIG. 3, the bag-like container 1 is sealed by the clamp 300, and the portion 14A of the storage portion 14 of the bag-like container 1 The internal volume of the container may be adjusted to be close to the volume of the contents. In addition, FIG. 3 is the figure which put the bag-like container 1 which accommodated the reaction liquid mixture 201 and the gaseous phase 202, sealed by the clamp 300 on the horizontal surface, and was planarly viewed. As shown in FIG. 3, when the reaction mixture and the gas phase are contained only in one portion without using the entire container of the bag-like container, the width A in the lateral direction and the width B in the longitudinal direction This refers to the width in the lateral direction and the width in the longitudinal direction in plan view of the portion containing the liquid and the gas phase. Specifically, as shown in FIG. 3, when the reaction liquid mixture and the gas phase are stored only in the portion 14A of the storage portion 14 formed by sealing the bag-like container 1 by the clamp 300, the storage portion 14 The lateral width of the portion 14A is A, and the longitudinal width is B.
 上記割合で反応混合液及び気相を収容し閉塞した袋状容器を振盪する方法としては、袋状容器を、水平面又は水平面と交差する面(特に水平面に対し略垂直な面)上で、直線往復動、閉じた軌道に沿った旋回動、及び/又は、回動させる方法が挙げられる。これらの振盪方法により、細胞を生きた細胞の状態で細胞含有試料から遊離させることが可能である。ここで水平面に対して略垂直な面とは、水平面との間で成す角が例えば70°~90°の平面を指す。図1に示す袋状容器1のように、2枚のシートを対向配置し周囲を接合して形成した袋状容器を振盪させる場合には、前記水平面又は水平面と交差する面と、2枚のシートが対向する方向とが垂直になるように、袋状容器を配置し、前記水平面又は水平面と交差する面上で袋状容器を振盪することが好ましい。 As a method of shaking the bag-like container containing the reaction mixture and the gas phase at the above ratio and closed, the bag-like container is a straight line on a horizontal surface or a surface intersecting with the horizontal surface (particularly, a surface substantially perpendicular to the horizontal surface) Reciprocating motion, pivoting along a closed track, and / or a method of pivoting may be mentioned. These shaking methods allow cells to be released from cell-containing samples in the form of live cells. Here, a plane substantially perpendicular to the horizontal plane means a plane having an angle of, for example, 70 ° to 90 ° with the horizontal plane. In the case of shaking a bag-like container formed by arranging two sheets facing each other and bonding the periphery as in the bag-like container 1 shown in FIG. 1, a plane intersecting the horizontal plane or the horizontal plane, and two sheets It is preferable to arrange the bag-like container so that the direction in which the sheets face each other is perpendicular, and shake the bag-like container on the horizontal plane or a plane intersecting the horizontal plane.
 袋状容器を振盪させる工程の時間、温度は、細胞含有試料及び酵素の種類や濃度に応じて適宜設定すればよく、例えば10~40分間、25~40℃が例示できる。 The time and temperature of the step of shaking the bag-like container may be appropriately set according to the type and concentration of the cell-containing sample and the enzyme, and can be, for example, 25 to 40 ° C. for 10 to 40 minutes.
 反応混合液と所定量の気相とを含む袋状容器を振盪させる工程により、袋状容器内で、細胞含有試料が酵素処理され、生きた状態で細胞が遊離する。遊離した細胞は、フィルター濾過、遠心分離等の方法で反応混合液から分離し、必要に応じて洗浄して回収することができる。 In the step of shaking the bag-like container containing the reaction mixture and a predetermined amount of gas phase, the cell-containing sample is enzymatically treated in the bag-like container and the cells are released in a living state. The released cells can be separated from the reaction mixture by a method such as filter filtration or centrifugation, and can be washed and recovered as necessary.
 5名の人(ドナー1、ドナー2、ドナー3、ドナー4、ドナー5)からの脂肪組織を、コラゲナーゼにより処理し、細胞懸濁液を調製する工程を異なる条件で行った。 The adipose tissue from 5 persons (donor 1, donor 2, donor 3, donor 4, donor 5) was treated with collagenase and the steps of preparing the cell suspension under different conditions.
 下記の第1の酵素処理用バッグ及び第2の酵素処理用バッグは共に図1に示す袋状容器1の具体例である。 The following first enzyme treatment bag and second enzyme treatment bag are both specific examples of the bag-like container 1 shown in FIG.
 第1の酵素処理用バッグ(袋状容器1)として、厚さ0.4mmの軟質ポリ塩化ビニルの概ね長方形の柔軟なシート11、12を2枚対向配置し、長手方向の一端の辺上に第1入口ポート21、第2入口ポート22、第3入口ポート23を設け、他端の辺上に第1出口ポート31、第2出口ポート32を設け、周縁部を熱融着により融着して融着部13を形成することで、前記2枚のシート11、12に挟まれた、空の状態で内寸が幅114mm、長さ196mmの概ね長方形の収容部14が形成されたバッグを用いた。第1の酵素処理用バッグの収容部14の内容積(収容部14が収容できる収容物の最大体積)は約600mLである。 As a first bag for enzyme treatment (bag-like container 1), two roughly rectangular flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are disposed opposite to each other, and on one end side in the longitudinal direction A first inlet port 21, a second inlet port 22, and a third inlet port 23 are provided, and a first outlet port 31 and a second outlet port 32 are provided on the other end side, and the peripheral portion is fused by heat fusion. Forming a fusion-bonded portion 13 to form a bag, which is sandwiched between the two sheets 11 and 12 and has a substantially rectangular housing portion 14 with an inner dimension of 114 mm wide and 196 mm long in an empty state Using. The internal volume (the maximum volume of the contents that can be accommodated by the accommodation portion 14) of the accommodation portion 14 of the first enzyme treatment bag is about 600 mL.
 第2の酵素処理用バッグ(袋状容器1)として、厚さ0.4mmの軟質ポリ塩化ビニルの概ね長方形の柔軟なシート11、12を2枚対向配置し、長手方向の一端の辺上に第1入口ポート21、第2入口ポート22、第3入口ポート23を設け、他端の辺上に第1出口ポート31、第2出口ポート32を設け、周縁部を熱融着により融着して融着部13を形成することで、前記2枚のシート11、12に挟まれた、空の状態で内寸が幅67mm、長さ116mmの概ね長方形の収容部14が形成されたバッグを用いた。第2の酵素処理用バッグの収容部14の内容量は約120mLである。 As a second bag for enzyme treatment (bag-like container 1), two roughly rectangular flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are disposed opposite to each other, and one end side in the longitudinal direction A first inlet port 21, a second inlet port 22, and a third inlet port 23 are provided, and a first outlet port 31 and a second outlet port 32 are provided on the other end side, and the peripheral portion is fused by heat fusion. Forming a fusion-bonded portion 13 to form a bag, which is sandwiched between the two sheets 11 and 12 and has a substantially rectangular storage portion 14 having an inner dimension of 67 mm in width and 116 mm in length in an empty state Using. The internal volume of the storage portion 14 of the second enzyme treatment bag is about 120 mL.
 第3の酵素処理用バッグ(袋状容器1)を図4に、第4の酵素処理用バッグ(袋状容器1)を図5に、第5の酵素処理用バッグ(袋状容器1)を図6に、それぞれ示す。 The third enzyme treatment bag (bag-like container 1) is shown in FIG. 4, the fourth enzyme treatment bag (bag-like container 1) in FIG. 5, and the fifth enzyme treatment bag (bag-like container 1) Each is shown in FIG.
 図4に示す第3の酵素処理用バッグ(袋状容器1)は、厚さ0.4mmの軟質ポリ塩化ビニルの概ね正方形の柔軟なシート11、12を2枚対向配置し、1つの辺上に入口ポート41、出口ポート51を設け、周縁部を熱融着により融着して融着部13を形成することで、前記2枚のシート11、12に挟まれた、空の状態で内寸が幅58mm、長さ58mmの概ね正方形の収容部14が形成されたバッグである。第3の酵素処理用バッグの収容部14の内容量は約43mLである。 In the third bag for enzyme treatment (bag-like container 1) shown in FIG. 4, two approximately square flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are disposed opposite to each other, and on one side The inlet port 41 and the outlet port 51 are provided, and the peripheral portion is fusion-bonded by heat fusion to form the fusion-bonded portion 13 so that the two sheets 11 and 12 are sandwiched between the two in an empty state. It is a bag in which a substantially square housing portion 14 having a size of 58 mm in width and 58 mm in length is formed. The internal volume of the container 14 for the third enzyme treatment bag is about 43 mL.
 図5に示す第4の酵素処理用バッグ(袋状容器1)は、厚さ0.4mmの軟質ポリ塩化ビニルの概ね長方形の柔軟なシート11、12を2枚対向配置し、長手方向の一端の辺上に入口ポート兼出口ポート61を設け、周縁部を熱融着により融着して融着部13を形成することで、前記2枚のシート11、12に挟まれた、空の状態で内寸が幅1323mm、長さ252mmの概ね長方形の収容部14が形成されたバッグである。第4の酵素処理用バッグの収容部14の内容量は約33mLである。 The fourth bag for enzyme treatment (bag-like container 1) shown in FIG. 5 has two substantially rectangular flexible sheets 11 and 12 of soft polyvinyl chloride of 0.4 mm in thickness disposed opposite to each other, and one end in the longitudinal direction The inlet port / outlet port 61 is provided on the side of the sheet, and the peripheral part is fusion-bonded by heat fusion to form the fusion-bonded part 13 so that the two sheets 11 and 12 are empty. In the bag, a substantially rectangular housing portion 14 having an inner dimension of 1323 mm and a length of 252 mm is formed. The internal volume of the container 14 for the fourth enzyme treatment bag is about 33 mL.
 図6に示す第5の酵素処理用バッグ(袋状容器1)は、厚さ0.4mmの軟質ポリ塩化ビニルの概ね長方形の柔軟なシート11、12を2枚対向配置し、長手方向の一端の辺上に入口ポート兼出口ポート61を設け、周縁部を熱融着により融着して融着部13を形成することで、前記2枚のシート11、12に挟まれた、空の状態で内寸が幅18mm、長さ187.7mmの概ね長方形の収容部14が形成されたバッグである。第5の酵素処理用バッグの収容部14の内容量は約22mLである。 In the fifth bag for enzyme treatment (bag-like container 1) shown in FIG. 6, two approximately rectangular flexible sheets 11 and 12 of soft polyvinyl chloride having a thickness of 0.4 mm are oppositely disposed, and one end in the longitudinal direction The inlet port / outlet port 61 is provided on the side of the sheet, and the peripheral part is fusion-bonded by heat fusion to form the fusion-bonded part 13 so that the two sheets 11 and 12 are empty. The bag is a bag in which a substantially rectangular housing portion 14 having an inner dimension of 18 mm in width and 187.7 mm in length is formed. The internal volume of the container 14 for the fifth enzyme treatment bag is about 22 mL.
 遠沈管として、ポリプロピレン製の内容量が50mLの遠沈管を用いた。
 第1又は第2の酵素処理用バッグ1の第1出口ポート31及び第2出口ポート32を蓋313、323で封鎖し、収容部14内に、10~50mLの脂肪組織と、10~50mLのコラゲナーゼ液(コラゲナーゼ濃度0.1w/v%となるようにコラゲナーゼを生理食塩液で溶解して調製)とを、脂肪組織とコラゲナーゼ液との体積比が1:1~1:3となるように収容して反応混合液201とし、収容部14内の空気相202の体積が、収容部14の体積(すなわち反応混合液201と空気相202との合計体積)に対して表1に示す所定の割合(%)となるように空気を加えて、第1又は第2の酵素処理用バッグ1の第1入口ポート21、第2入口ポート22、第3入口ポート24を蓋213、223、233で封鎖して密封した。
As a centrifuge tube, a 50 mL centrifuge tube made of polypropylene was used.
The first outlet port 31 and the second outlet port 32 of the first or second enzyme treatment bag 1 are closed with lids 313 and 323, and 10 to 50 mL of fat tissue and 10 to 50 mL of fat tissue are contained in the storage unit 14. Collagenase solution (prepared by dissolving collagenase with physiological saline so that the concentration of collagenase is 0.1 w / v%) and the volume ratio of adipose tissue to collagenase solution are 1: 1 to 1: 3. The volume of the air phase 202 in the storage unit 14 is set as shown in Table 1 with respect to the volume of the storage unit 14 (that is, the total volume of the reaction mixture 201 and the air phase 202). Add air so as to become a percentage (%), the first inlet port 21, the second inlet port 22, and the third inlet port 24 of the first or second bag for enzyme treatment 1 with lids 213, 223, 233. Sealed and sealed.
 同様に、第3の酵素処理用バッグ1の出口ポート51を蓋313で封鎖し、収容部14内に、20mLの脂肪組織と、20mLのコラゲナーゼ液とを収容して反応混合液201とし、収容部14内の空気相202の体積が収容部14の体積に対して7%となるように3mLの空気を加え、第3の酵素処理用バッグ1の入口ポート41を蓋413で封鎖して密封した。 Similarly, the outlet port 51 of the third enzyme treatment bag 1 is closed with a lid 313, and 20 mL of adipose tissue and 20 mL of collagenase solution are accommodated in the accommodation portion 14 to form a reaction mixture solution 201, and is accommodated. 3 mL of air is added so that the volume of the air phase 202 in the section 14 becomes 7% of the volume of the accommodation section 14, and the inlet port 41 of the third enzyme treatment bag 1 is sealed with a lid 413 for sealing did.
 同様に、第4の酵素処理用バッグ1の収容部14内に、15mLの脂肪組織と、15mLのコラゲナーゼ液とを収容して反応混合液201とし、収容部14内の空気相202の体積が収容部14の体積に対して7%となるように2.2mLの空気を加え、第4の酵素処理用バッグ1の入口ポート兼出口ポート61を蓋613で封鎖して密封した。 Similarly, 15 mL of fat tissue and 15 mL of collagenase solution are stored in the storage portion 14 of the fourth enzyme processing bag 1 to form a reaction mixture 201, and the volume of the air phase 202 in the storage portion 14 is 2.2 mL of air was added so as to be 7% with respect to the volume of the housing portion 14, and the inlet port / outlet port 61 of the fourth enzyme treatment bag 1 was sealed with a lid 613 and sealed.
 同様に、第5の酵素処理用バッグ1の収容部14内に、10mLの脂肪組織と、10mLのコラゲナーゼ液とを収容して反応混合液201とし、収容部14内の空気相202の体積が収容部14の体積に対して7%となるように1.5mLの空気を加え、第5の酵素処理用バッグ1の入口ポート兼出口ポート61を蓋613で封鎖して密封した。 Similarly, 10 mL of fat tissue and 10 mL of collagenase solution are stored in the storage portion 14 of the fifth bag 1 for enzyme treatment to form a reaction liquid mixture 201, and the volume of the air phase 202 in the storage portion 14 is 1.5 mL of air was added so as to be 7% with respect to the volume of the housing portion 14, and the inlet port / outlet port 61 of the fifth enzyme treatment bag 1 was sealed with a lid 613 and sealed.
 ここで、ドナー1、ドナー2又はドナー3からの脂肪組織を用いた試験では、酵素処理用バッグとして第1の酵素処理用バッグを用いた。ドナー4からの脂肪組織を用いた試験では、酵素処理用バッグとして第2の酵素処理用バッグを用いた。ドナー5からの脂肪組織を用いた試験では、酵素処理用バッグとして第3~第5の酵素処理用バッグを用いた。 Here, in the test using adipose tissue from donor 1, donor 2 or donor 3, the first enzyme treatment bag was used as the enzyme treatment bag. In the test using fat tissue from the donor 4, a second enzyme treatment bag was used as the enzyme treatment bag. In the tests using adipose tissue from the donor 5, third to fifth enzyme treatment bags were used as enzyme treatment bags.
 第1の酵素処理用バッグの収容部の内容積は600mLであるのに対して、脂肪組織とコラゲナーゼ液とを含む反応混合液と気相とからなる収容物は最大でも100mLであり内容量と比較して体積が小さい。このため、第1の酵素処理用バッグを用いる試験では、収容部に反応混合液と気相とを収容した第1の酵素処理用バッグを、図3に示すようにクランプ300により一部を封止して、第1の酵素処理用バッグ1の収容部14のうち、収容物(反応混合液と気相)を収容する部分14Aの、図3中「A」で示す短手方向幅を、表1に示すように100mm又は75mmとなるように調節した。 The internal volume of the first enzyme treatment bag is 600 mL, while the content of the reaction mixture containing fatty tissue and collagenase solution and the gas phase is at most 100 mL. The volume is small in comparison. For this reason, in the test using the first enzyme treatment bag, the first enzyme treatment bag containing the reaction mixture and the gas phase in the storage portion is partially sealed by the clamp 300 as shown in FIG. Then, in the accommodation portion 14 of the first enzyme treatment bag 1, the width direction width indicated by "A" in FIG. As shown in Table 1, it adjusted so that it might be set to 100 mm or 75 mm.
 収容部の内容量が約120mL、約43mL、約33mL及び約22mLである第2、第3、第4及び第5の酵素処理用バッグを用いる場合は、そのような調節は行わなかった。 Such adjustment was not performed when using the second, third, fourth and fifth bags for enzyme treatment in which the internal volume of the container was about 120 mL, about 43 mL, about 33 mL and about 22 mL.
 前記遠沈管を用いる試験では、前記遠沈管に、10~23.3mLの脂肪組織と、20~30mLのコラゲナーゼ液(コラゲナーゼ濃度0.1w/v%となるように生理食塩液で溶解して調製した)とを、脂肪組織とコラゲナーゼ液との体積比が1:1~1:3となるように収容し蓋を閉じて密閉した。このとき、前記遠沈管内の気相の体積は、遠沈管内体積(脂肪組織とコラゲナーゼ液と気相との合計体積)に対して20%又は7%であった。 In the test using the centrifuge tube, the centrifuge tube is prepared by dissolving 10 to 23.3 mL of adipose tissue and 20 to 30 mL of collagenase solution (a concentration of collagenase is 0.1 w / v% with physiological saline). ) And the lid was closed and sealed so that the volume ratio of adipose tissue to collagenase solution was 1: 1 to 1: 3. At this time, the volume of the gas phase in the centrifuge tube was 20% or 7% with respect to the volume of the centrifuge tube (total volume of fat tissue, collagenase solution and gas phase).
 脂肪組織、コラゲナーゼ液及び気相を収容した第1~第5の酵素処理用バッグ或いは遠沈管を37℃、30分間、60rpm(ドナー1、2の脂肪組織試料を用いる場合は200rpm)の条件でシェーカーにより振盪させ酵素反応を行った。第1~第5の酵素処理用バッグを振盪する場合、シェーカーの振盪台の設置面に、前記バッグを構成する2枚のシート11、12の一方の側が接するように前記バッグを固定し、振盪台をその設置面に沿った方向に振盪させることで前記バッグを振盪させた。 The first to fifth enzyme treatment bags or centrifuge tubes containing fat tissue, collagenase solution and gas phase are subjected to conditions of 60 rpm (200 rpm when using donors 1 and 2 fat tissue samples) for 30 minutes at 37 ° C. The enzyme reaction was carried out by shaking with a shaker. When the first to fifth enzyme treatment bags are shaken, the bag is fixed so that one side of the two sheets 11 and 12 constituting the bag is in contact with the installation surface of the shaker table, and the shaking is performed. The bag was shaken by shaking the platform in the direction along the mounting surface.
 30分の酵素反応後に、第1~第5の酵素処理用バッグ或いは遠沈管を静置して反応混合液を水層(下層)と脂肪を含む油層(上層)とに分離し、水層を回収し、水層中の有核細胞数及び脂肪由来幹細胞数をフローサイトメーターおよびBD TrucountTubesを用いて測定した。有核細胞数は、CD34陽性細胞数とCD45陽性細胞数の和から算出した。同様に、脂肪由来幹細胞数は、CD34陽性/CD45陰性/CD31陰性の細胞数から算出した。
 結果を表1に示す。
After the enzyme reaction for 30 minutes, the first to fifth enzyme treatment bags or centrifuge tubes are allowed to stand to separate the reaction mixture into an aqueous layer (lower layer) and an oil layer containing fat (upper layer), and the aqueous layer is separated. The number of nucleated cells and the number of adipose-derived stem cells in the aqueous layer were collected using a flow cytometer and BD TrucountTubes. The number of nucleated cells was calculated from the sum of the number of CD34 positive cells and the number of CD45 positive cells. Similarly, the number of adipose-derived stem cells was calculated from the number of CD34 positive / CD45 negative / CD31 negative cells.
The results are shown in Table 1.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-I000002
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-I000002
 本明細書で引用した全ての刊行物、特許及び特許出願はそのまま引用により本明細書に組み入れられるものとする。 All publications, patents and patent applications cited herein are incorporated herein by reference in their entirety.

Claims (3)

  1.  細胞含有試料を酵素処理して、細胞含有試料から細胞を遊離させる方法であって、
     細胞含有試料と酵素とを含む反応混合液及び気相を、反応混合液と気相との合計体積に対して気相の体積が7体積%以上となる割合で収容し閉鎖した袋状容器を振盪させる工程を含むことを特徴とする方法。
    A method of enzymatically treating a cell-containing sample to release cells from the cell-containing sample,
    A closed container comprising a reaction mixture containing a cell-containing sample and an enzyme and a gas phase is contained at a ratio of 7 vol% or more of the volume of the gas phase to the total volume of the reaction mixture and the gas phase. A method characterized in that it comprises the step of shaking.
  2.  細胞含有試料が脂肪組織である、請求項1に記載の方法。 The method according to claim 1, wherein the cell-containing sample is adipose tissue.
  3.  袋状容器の反応混合液及び気相を収容する収容部の、平面視での、短手方向幅をAとし長手方向幅をBとしたとき、A/Bが0.1以上1以下である、請求項1又は2に記載の方法。 A / B is 0.1 or more and 1 or less, where the width in a widthwise direction is A and the width in a longitudinal direction is B in plan view of the container containing the reaction mixture and the gas phase of the bag-like container The method according to claim 1 or 2.
PCT/JP2018/034107 2017-09-15 2018-09-14 Method of freeing cells from cell-containing sample WO2019054468A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019542298A JP7282679B2 (en) 2017-09-15 2018-09-14 Method for releasing cells from cell-containing sample

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-178267 2017-09-15
JP2017178267 2017-09-15

Publications (1)

Publication Number Publication Date
WO2019054468A1 true WO2019054468A1 (en) 2019-03-21

Family

ID=65722830

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/034107 WO2019054468A1 (en) 2017-09-15 2018-09-14 Method of freeing cells from cell-containing sample

Country Status (2)

Country Link
JP (1) JP7282679B2 (en)
WO (1) WO2019054468A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012480A2 (en) * 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue
JP2007185157A (en) * 2006-01-16 2007-07-26 Kaneka Corp Method for collecting nucleated cell from enzymic treatment liquid of fatty tissue
JP2010136628A (en) * 2008-12-09 2010-06-24 Ihi Corp Cell culture bag and cell culture method thereof
JP2011078317A (en) * 2009-10-02 2011-04-21 Olympus Corp Fat tissue digestion apparatus and cell separation apparatus
JP2011172545A (en) * 2010-02-25 2011-09-08 Olympus Corp Cell separation apparatus
JP2015092852A (en) * 2013-11-12 2015-05-18 倉敷紡績株式会社 Composition for biological tissue dispersion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068775A (en) * 1998-04-13 2000-05-30 Circe Biomedical, Inc. Removal of agent from cell suspension
EP1670315B1 (en) 2003-09-17 2017-04-19 Cytori Therapeutics, Inc. Methods of using adipose derived regenerative cells in the treatment of peripheral vascular disease
JP2010239891A (en) 2009-04-03 2010-10-28 Olympus Corp Apparatus for adipose tissue separation
KR20140147805A (en) 2011-12-07 2014-12-30 아바스템 바이오메디컬 코퍼레이션 Method and device for isolation of non-fat cells from an adipose tissue

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012480A2 (en) * 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue
JP2007185157A (en) * 2006-01-16 2007-07-26 Kaneka Corp Method for collecting nucleated cell from enzymic treatment liquid of fatty tissue
JP2010136628A (en) * 2008-12-09 2010-06-24 Ihi Corp Cell culture bag and cell culture method thereof
JP2011078317A (en) * 2009-10-02 2011-04-21 Olympus Corp Fat tissue digestion apparatus and cell separation apparatus
JP2011172545A (en) * 2010-02-25 2011-09-08 Olympus Corp Cell separation apparatus
JP2015092852A (en) * 2013-11-12 2015-05-18 倉敷紡績株式会社 Composition for biological tissue dispersion

Also Published As

Publication number Publication date
JPWO2019054468A1 (en) 2020-10-15
JP7282679B2 (en) 2023-05-29

Similar Documents

Publication Publication Date Title
JP6164612B2 (en) Cell separation container
ES2674410T3 (en) Method for preparing adipose tissue for transplantation of lobular fat removed by liposuction
EP1926557B1 (en) Kit for preparing a composition comprising fat cells
EP2550357B1 (en) Cell-culture-bag
KR101307672B1 (en) Method for controlling propagation of umbilical cord blood hematopoietic stem cells and use thereof
US8721617B2 (en) Liquid component collecting device
JP7300486B2 (en) Separation, dissociation and/or disaggregation of cells using shock waves or mechanical impact
ES2837096T3 (en) Device for isolating cell fractions from human and animal tissues and procedure for their use
JP2008011778A (en) Method for preserving langerhans&#39; islets, container for preserving langerhans&#39; islets and kit for transplanting langerhans&#39; islets
WO2019054468A1 (en) Method of freeing cells from cell-containing sample
WO2019059279A1 (en) Device, system and method for preparing cell suspension
JP5738582B2 (en) Cell solution processing instrument provided with a member that facilitates removal of bubbles during priming and method of using the same
WO2019059278A1 (en) Method for separating and collecting cells from biological tissue
JP2001161352A (en) Method for separating cell for regenerating biotissue, cell for regenerating biotissue and apparatus for separating cell for regenerating biotissue
KR101110051B1 (en) Bag for centrifugal separation and method of centrifugal separation using bag for centrifugal separation
WO2012011705A2 (en) Centrifuge cell strainer and centrifuge method using same
WO2021220057A2 (en) Automated integrated liposuction and tissue processing device and method
AU2015275279A1 (en) Apparatus and method for processing biological material
JP2004159584A (en) Endocrine cell concentrator
JP2009213573A (en) Separation method of rat pancreatic islet

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18857285

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019542298

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18857285

Country of ref document: EP

Kind code of ref document: A1